000 | 01162 a2200289 4500 | ||
---|---|---|---|
005 | 20250517110501.0 | ||
264 | 0 | _c20170327 | |
008 | 201703s 0 0 eng d | ||
022 | _a1349-2896 | ||
024 | 7 |
_a10.2183/pjab.92.222 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKanai, Yoshiyuki | |
245 | 0 | 0 |
_aOverview on poly(ADP-ribose) immuno-biomedicine and future prospects. _h[electronic resource] |
260 |
_bProceedings of the Japan Academy. Series B, Physical and biological sciences _c2016 |
||
300 |
_a222-36 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies _ximmunology |
650 | 0 | 4 |
_aHistones _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xblood |
650 | 0 | 4 |
_aNerve Degeneration _xdrug therapy |
650 | 0 | 4 |
_aPoly Adenosine Diphosphate Ribose _xchemistry |
650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerase Inhibitors _xpharmacology |
773 | 0 |
_tProceedings of the Japan Academy. Series B, Physical and biological sciences _gvol. 92 _gno. 7 _gp. 222-36 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2183/pjab.92.222 _zAvailable from publisher's website |
999 |
_c26283958 _d26283958 |